Open original FDA record ↗Recall record
- FDA identifier
- Z-2152-2016
- Company in FDA record
- Synthes (USA) Products LLC
- FDA classification date
- Jul 11, 2016
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Labeling does not match the cleared indications for use in the United States and Canada.
Source facts
- Action
- DePuy Synthes initiated a Field Safety Notice to remove the affected Technique Guides and marketing literature from the field. Sales Consultants and Synthes Trauma Marketing will receive training on affected technique guides and marketing literature which promoted off label use. All technique guides and literature have been put on hold and removed from DePuy Synthes website. Effectiveness of this field action will be tracked using their training system. They will confirm training when completed as a means to measure effectiveness.
- Initiated
- 2016-02-16
- Root cause
- Labeling False and Misleading
- Terminated
- 2017-06-01
- Distribution
- US Nationwide Distribution in the states of :AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, N/A, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, and WY.
- Recall number
- Z-2152-2016
- Recall status
- Terminated
- CDRH record ID
- 147058
- FDA classified
- 2016-07-11
- Recall event number
- 74283